Source: iQoncept / Shutterstock
ZyVersa Therapeutics (NASDAQ:ZVSA) just reported results for the first quarter of 2024.
- ZyVersa Therapeutics reported earnings per share of -$4.53. This was below the analyst estimate for EPS of -$3.70.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/zvsa-stock-earnings-zyversa-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC